Company:Roche Diagnostics
 | |
| Industry | IVD industry |
|---|---|
| Headquarters | Rotkreuz , Switzerland |
| Website | diagnostics |
Roche Diagnostics is a diagnostic division of Hoffmann-La Roche which manufactures equipment and reagents, for research and medical diagnostic applications. Internally, it is organized into five major business areas: Roche Applied Science, Roche Professional Diagnostics, Roche Diabetes Care, Roche Molecular Diagnostics and Roche Tissue Diagnostics (Ventana). The main location for Roche Professional Diagnostics is in Rotkreuz, Switzerland.
All business areas except Roche Applied Science focus on health care applications, targeting either physicians, hospitals and clinics, or consumers. Applied Science targets research settings in academia and pharmaceutical and biotechnology industries.
Awards and honors
The firm was named by Fortune magazine as one of the top 100 companies to work from 2012 through 2017, citing that employee amenities "include an on-site medical clinic and fitness center, a $30,000 budget for intramural sports, and health insurance plans tiered to income levels."[1]
On March 13, 2020 Roche developed an FDA-approved test which can detect SARS-CoV-2 within 3.5 hours[2]
References
- ↑ https://money.cnn.com/magazines/fortune/best-companies/2013/snapshots/89.html?iid=bc_lp_arrow1
- ↑ www.ETHealthworld.com. "US regulators approve Roche's new and faster COVID-19 test - ET HealthWorld" (in en). https://health.economictimes.indiatimes.com/news/pharma/us-regulators-approve-roches-new-and-faster-covid-19-test/74613941.
External links
 |
